New Horizons in AF - Personalised AF Therapies
Published: 23 January 2020
New Horizons in AF was a scientific meeting which highlighted current approaches to the diagnosis and treatment of atrial fibrillation. The meeting hosted faculty from across the globe and each presenter shared their personalised AF therapy strategies. Access here a collection of key presentations from the meeting.
- Understand different approaches to AF diagnosis and treatment
- Understand two new single-shot technologies
- Understand AF treatment with RHYTHMIA HDx™
Welcome & Current State of the Art
The Big AF Debate
Introducing the AF Portfolio Proposition
Personalised AF Therapies in the Hands of All EPs
Ultra-HD Mapping and Ablation
Prof Isabel Deisenhofer is an electrophysiologist at the German Heart Center Munich, Germany. Prof Deisenhofer's specialities include arrythmias, atrial fibrillation, ventricular arrythmias and sudden cardiac death.
Professor John Morgan is an honorary professor of Cardiac Rhythm Management, Cardiology at the University of Southampton. Prof Morgan specialises in cardiac arrhythmias and is the CMO EMEA, Rhythm Management, Boston Scientific.
Prof Dr Serge Boveda, Clinique Pasteur, Toulouse, FRProf Dr Boveda (MD, PhD, FESC, FEHRA) is a specialist in cardiovascular diseases and the interventional treatment of cardiac arrhythmias since 1994. He is co-head of the Cardiac Arrhythmia Management Department at the Clinique Pasteur Toulouse (France), and Guest Professor for education in the postgraduate course of EP & Pacing, and research in the domain of EP at the Brussels University of Medicine (VUB).He is currently the president of the arrhythmia working group of the French Society of Cardiology (SFC) since 2018, and faculty of the French national graduation on cardiac arrhythmias (Diplôme Inter Universitaire de Rhythmologie) since 2002.Finally he is the co-founder and coordinator of the European Network for the Treatment of Cardiac Arrhythmias (RETAC), and the co-chair of EHRA's Scientific Documents Committee in 2018-2020.